Abstract
Swine producers in the U.S. face a significant challenge. On top of the ever-changing market dynamics that lead to wide swings in profitability or loss, is an underlying issue of pig mortality that the industry must address. While significant improvements in total piglets born per litter have been achieved over the last 10 years, pig mortality has seen no improvement or has worsened (Figure 1). When expressed as a percentage of piglets born (excluding mummies), a total of 7.9% were recorded as stillborn and 13.4% died prior to weaning in 2019. Assuming a typical mortality range of 7–10% from weaning to harvest, a typical U.S. producer could expect to lose around 27–30% of all piglets born. In addition, the average producer had around 12% annual sow mortality (Figure 1). Litter size and post-weaning growth rate and feed efficiency will always factor heavily into research priorities due to the economic impact associated with those traits; however, the opportunity to drive value through reduction in pig losses across the production cycle is staggering. In defense of the industry, improving pig survival is not an easy task for a number of reasons. The sample size (i.e., number of pigs) required to do mortality research correctly is often a limiting factor for many production systems. Furthermore, a cross-functional approach is likely required to make significant improvements in mortality. Specifically, the relationship between genetics, health, and management practices warrant consideration. Recent collaboration across the industry to improve mortality is a positive step forward and this collaboration should continue moving forward.